TB-500 30mg — Vial Spec, Reconstitution Math & COA

A 30mg vial of TB-500 provides a high-mass lyophilized yield designed specifically for high-throughput in vitro bioassays and multi-subject preclinical research protocols. This technical guide outlines the molecular specifications, dilution mathematics, aliquot management, and lot-specific analytical validation for 30mg TB-500 research compounds.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A 30mg vial of TB-500 provides a high-mass lyophilized yield designed specifically for high-throughput in vitro bioassays and multi-subject preclinical research protocols. This technical guide outlines the molecular specifications, dilution mathematics, aliquot management, and lot-specific analytical validation for 30mg TB-500 research compounds.

Reviewed by PX1 Research scientific team

Key takeaways

  • A 30mg vial of [TB-500](/research-peptides/tb-500) contains 30,000 micrograms (µg) of highly purified, sterile-filtered, and lyophilized synthetic peptide powder.
  • [TB-500](/research-peptides/tb-500) is a synthetic peptide analog based on the functional domain of naturally occurring Thymosin Beta-4 (Tβ4).
  • To maintain optimal peptide stability and minimize post-reconstitution chemical degradation, PX1 Research maintains the standard stock format of this compound in high-purity single-vial units.
  • Reconstituting a high-mass 30mg lyophilized cake requires careful calculation to ensure exact working concentrations.

Overview of the TB-500 30mg Research Vial Format

A 30mg vial of TB-500 contains 30,000 micrograms (µg) of highly purified, sterile-filtered, and lyophilized synthetic peptide powder. This larger unit mass is specifically engineered for high-volume research applications, including multi-subject rodent cohorts, continuous cell culture series, and high-throughput screening assays where frequent reconstitutions from smaller vials would introduce excessive inter-assay variability.

By consolidating 30mg of active peptide into a single vacuum-sealed glass vial, laboratory procurement teams reduce packaging waste, streamline inventory tracking, and ensure consistent batch parameters across extended testing protocols. Investigators ordering the 30mg bulk format typically operate contract research organizations (CROs), university biomedical departments, or private biotechnology laboratories conducting extensive tissue regeneration experiments.

Molecular Identity and Preclinical Mechanisms of Action

TB-500 is a synthetic peptide analog based on the functional domain of naturally occurring Thymosin Beta-4 (Tβ4). Specifically, it encompasses the active N-terminal sequence—frequently studied for its role as a key intracellular actin-sequestering peptide. As a primary regeneration peptide, TB-500 has been widely investigated for promoting cell migration, blood-vessel formation (angiogenesis), and structural flexibility during soft-tissue and muscle-fiber recovery in preclinical models.

In vitro data indicate that TB-500 binds unpolymerized G-actin monomers in a 1:1 complex, preventing spontaneous nucleation while maintaining a mobile pool of actin necessary for rapid microfilament assembly. Preclinical studies suggest that this regulated actin dynamics mechanism accelerates cell motility, allowing endothelial cells, keratinocytes, and myoblasts to migrate into damaged tissue zones. Furthermore, animal studies demonstrate that TB-500 supports localized vascular remodeling without inducing systemic inflammatory responses, making it a critical tool for studying extracellular matrix reorganization and cellular repair pathways.

PX1 Research Catalog Availability & Bulk Order Clarification

To maintain optimal peptide stability and minimize post-reconstitution chemical degradation, PX1 Research maintains the standard stock format of this compound in high-purity single-vial units. Principal researchers seeking off-the-shelf inventory should examine our flagship TB-500 10mg vial, which represents our standard production size for optimal shelf-life management.

While the standard stock catalog focuses on 10mg unit sizes, PX1 Research produces 30mg vials and larger bulk configurations upon request for institutional accounts and ongoing high-throughput research programs. Researchers wishing to explore our broader selection of synthetic peptides, analytical standards, and research formulations can inspect the full PX1 research peptide catalog for available fill volumes and ready-to-ship inventory.

Reconstitution Mathematics and Dilution Table for 30mg Vials

Reconstituting a high-mass 30mg lyophilized cake requires careful calculation to ensure exact working concentrations. Because 30mg represents a concentrated target mass, adding standard volumes of bacteriostatic water yields significantly higher milligram-per-milliliter ratios than smaller 2mg or 5mg vials.

Below is the core concentration matrix when adding typical volumes of diluent to a 30mg TB-500 vial:

• 1.0 mL Diluent = 30.0 mg/mL (30,000 µg/mL or 30 µg per microliter) • 2.0 mL Diluent = 15.0 mg/mL (15,000 µg/mL or 15 µg per microliter) • 3.0 mL Diluent = 10.0 mg/mL (10,000 µg/mL or 10 µg per microliter)

For custom concentration targets or fractional volume draws, researchers should utilize the interactive PX1 reconstitution calculator to verify micro-pipette volumetric settings prior to liquid transfer.

Aliquot Management and Handling Protocols for High-Mass Vials

When handling a 30mg reconstituted vial, aliquot planning is crucial. Leaving a 30mg yield in liquid phase inside a single multi-dose glass vial over extended periods increases the risk of peptide hydrolysis, oxidation, and contamination from repeated needle punctures.

To maximize structural integrity, laboratories should implement a strict aliquoting protocol upon reconstitution. Reconstitute the 30mg cake under a laminar flow hood using sterile bacteriostatic water (0.9% benzyl alcohol preserved). Once completely dissolved, divide the liquid volume into single-use, low-binding micro-centrifuge tubes (e.g., 100 µL to 500 µL per tube). Freeze these secondary aliquots immediately at -20°C or -80°C. Individual tubes can then be thawed once prior to specific assay runs, avoiding repeated freeze-thaw cycles that break peptide backbone bonds.

Storage Conditions, Temperature Control, and Aqueous Stability

Proper temperature control is essential for maintaining the target purity of TB-500 across its operational lifecycle. In its unfulfilled, lyophilized state, high-purity TB-500 remains stable at room temperature (15°C to 25°C) for short periods during transit. PX1 Research dispatches all items via same-day shipping (Monday through Friday) from centralized fulfillment centers in California and Arizona to limit ambient temperature exposure.

Upon arrival at the receiving facility, desiccated lyophilized vials should be stored at -20°C for long-term preservation (up to 24 months). Once reconstituted with bacteriostatic water, liquid solutions kept at 2°C to 8°C should be utilized within 21 to 28 days. Liquid solutions frozen without cryoprotectants or subjected to non-buffered pH environments may experience accelerated peptide aggregation.

Analytical Quality Assurance and Lot-Matched Certificates of Analysis

Every production lot of TB-500 manufactured for PX1 Research undergoes stringent analytical testing in an independent, ISO 17025 accredited laboratory. Quality control protocols verify chemical identity, purity thresholds, physical appearance, and biological safety profiles prior to lot release.

Analytical verification includes High-Performance Liquid Chromatography (HPLC) to confirm purity levels equal to or exceeding 98.0%, liquid chromatography-mass spectrometry (LC-MS) to verify molecular weight specifications, and Limulus Amebocyte Lysate (LAL) testing to enforce strict bacterial endotoxin limits (< 0.05 EU/mg). Investigators can access and download lot-matched documentation directly through the official PX1 COA database.

Selecting the Ideal Vial Size: 2mg, 5mg, 10mg vs. 30mg Formats

Determining whether a 2mg, 5mg, 10mg, or 30mg vial is optimal for a given research design depends on cohort size, assay duration, and target concentration requirements. Selecting the incorrect vial mass can lead to reagent degradation or excessive vial handling.

• 2mg or 5mg Vials: Ideal for short-duration pilot studies, single-subject cell culture treatments, or exploratory assays where minimum reconstituted storage time is desired. • 10mg Vials: The industry standard unit for routine preclinical protocols, balancing high working volume with manageable post-reconstitution usage windows. • 30mg Vials: Designed specifically for institutional high-throughput screening, multi-animal longitudinal models, or automated robotic dispensing platforms requiring large continuous liquid stocks.

Comparative Analysis: TB-500 alongside Complementary Repair Compounds

When designing comprehensive models for soft-tissue recovery and extracellular matrix dynamics, researchers frequently evaluate TB-500 alongside other prominent signaling peptides. While TB-500 operates primarily through G-actin sequestration and cell migration pathways, compounds like BPC-157 promote structural healing through focal adhesion kinase (FAK) activation and VEGFR2 angiogenesis cascades. Similarly, tripeptide complexes such as GHK-Cu modulate gene expression related to collagen remodeling and anti-inflammatory cellular signals. In broader metabolic recovery studies, investigators also examine growth hormone secretagogues like CJC-1295 DAC to observe systemic endocrine influences on tissue regeneration.

Institutional Procurement and Wholesale Ordering Protocols

PX1 Research supports university laboratories, government research agencies, and private biotechnology firms with dedicated commercial procurement channels. Institutional buyers requiring volume-discounted pricing, custom fill sizes (such as 30mg or 50mg custom orders), or specialized lot-reservation programs can establish direct supplier accounts.

To review commercial pricing schedules and bulk order specifications, visit the PX1 wholesale portal. For further scientific documentation, literature summaries, and technical specs across our peptide catalog, explore our curated peptide research hub.

Frequently Asked Questions

What does a 30mg vial of TB-500 contain?

A 30mg vial contains 30,000 micrograms of sterile, lyophilized TB-500 peptide powder, formulated for laboratory research use only. It contains no excipients or active pharmaceuticals meant for clinical administration.

Is the 30mg vial size currently available in the standard PX1 catalog?

PX1 Research maintains the 10mg TB-500 vial as its core stock size to ensure optimal post-reconstitution shelf life. However, 30mg vials and custom high-mass fills are manufactured for institutional clients via direct inquiry or wholesale custom synthesis.

How do I calculate the volume needed for a specific dose from a 30mg vial?

Divide the target mass by the total concentration of your reconstituted solution. For example, if 30mg is reconstituted in 3mL of diluent (10mg/mL concentration), a 1mg (1,000µg) sample requires 0.1mL (100µL) of solution.

What diluent should be used to reconstitute TB-500 30mg?

Laboratory protocols typically specify sterile Bacteriostatic Water (0.9% benzyl alcohol preserved) for multi-use analytical applications, or sterile 0.9% Sodium Chloride / Phosphate-Buffered Saline (PBS) for immediate in vitro cell culture assays.

How should reconstituted TB-500 30mg be stored?

Reconstituted liquid solutions should be stored at 2°C to 8°C and used within 21 to 28 days. For extended preservation, aliquot the reconstituted solution into single-use tubes and store at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles.

How does PX1 Research verify the quality of its TB-500 lots?

Each lot undergoes independent ISO 17025 lab testing including HPLC (purity ≥ 98.0%), LC-MS (mass characterization), and LAL endotoxin testing (< 0.05 EU/mg). Certificates of Analysis (COAs) are published online per lot.

What is the difference between TB-500 and full-length Thymosin Beta-4?

TB-500 is a synthetic peptide fragment containing the active actin-binding motif (LKKTET) of the naturally occurring 43-amino acid protein Thymosin Beta-4. It is designed to isolate specific cell migration and actin-regulatory dynamics in preclinical research.

What are the endotoxin limits enforced on PX1 TB-500 compounds?

PX1 Research enforces a strict endotoxin threshold of less than 0.05 EU/mg as measured by kinetic LAL assay, ensuring high suitability for sensitive cellular assays and preclinical models.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.